Proven Medical Testing
COVID-19/Flu A&B Antigen Test Pro - (25 pack)
COVID-19/Flu A&B Antigen Test Pro - (25 pack)
Couldn't load pickup availability
Need bulk pricing? Request a quote
The COVID-19/Flu A&B Antigen Test Pro is a lateral flow immunochromatographic assay for the qualitative detection and differentiation of influenza A and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen from anterior nasal swab samples, in individuals with signs and symptoms of respiratory tract infection.
- Three results from a single anterior nasal swab: COVID-19, Influenza A and Influenza B
- Results read between 15 and 20 minutes
- Procedural control line in both result windows confirms a valid run
- 25 sealed cassettes per box with pre-filled extraction tubes, tube tips and tube holders
For in vitro diagnostic use. Intended for use in individuals aged 2 years and older. Do not use the test if the patient has had symptoms for more than 5 days, or no symptoms at all. Sold to healthcare professionals only. Negative results are presumptive and should be confirmed with an FDA-cleared molecular assay when determined to be appropriate by a healthcare provider. Positive results do not rule out co-infection with other respiratory pathogens.
VIEW INSTRUCTIONS FOR USE (PDF)
Volume pricing: 10% off when you buy 10 or more boxes and 20% off at 50 or more boxes, applied automatically at checkout. For 200 or more boxes, contact us for a quote.
Specifications
Specifications
| Manufacturer | Proven Medical Testing |
|---|---|
| Sold by | Box of 25 tests |
| Sample type | Anterior nasal swab (direct) |
| Time to results | 15 minutes (read between 15 and 20 minutes) |
| Storage temperature | 36–86°F (2–30°C), out of direct sunlight |
| Sterility | Sterile nasal swabs (25); other components supplied non-sterile |
| Disposable | Yes, single-use cassette, swab and extraction tube |
| Catalog number (REF) | GCFC-5258Kcu |
| CPT code | 87812 (QW modifier for CLIA-waived sites) |
| CLIA complexity | Waived |
| FDA status | FDA De Novo authorized, Class II |
Kit contents
- 25 sealed test cassettes
- 25 sterile nasal swabs
- 25 pre-filled extraction tubes
- 25 extraction tube tips
- 2 tube holders
- 1 Instructions for Use (IFU)
- 1 Quick Reference Instructions (QRI)
Clinical performance
Clinical performance
- SARS-CoV-2: PPA/Sensitivity 92.0% (69/75), 95% CI 83.6–96.3%; NPA/Specificity 99.0% (1012/1022), 95% CI 98.2–99.5%
- Influenza A: PPA/Sensitivity 92.5% (49/53), 95% CI 82.1–97.0%; NPA/Specificity 99.9% (1068/1069), 95% CI 99.5–100.0%
- Influenza B: PPA/Sensitivity 90.5% (38/42), 95% CI 77.9–96.2%; NPA/Specificity 99.9% (1079/1080), 95% CI 99.5–100.0%
Prospective study at ten U.S. sites versus FDA-cleared RT-PCR, anterior nasal swabs, symptom onset 0–5 days (1,122 evaluable subjects). Instructions for Use rev. 2026-05-07, doc B25374-01.
